Skip to main content
. 2013 Mar;15(2):270–279. doi: 10.1016/j.jmoldx.2012.11.002

Figure 8.

Figure 8

Clinical performance of the developed PITX2 real-time PCR assay in the subgroup of patients with Gleason score 7 tumors and ≥75% tumor cell content in the sample. The figure shows a Kaplan-Meier analysis of BCR-free survival in patients stratified by PITX2 DNA methylation.